Wednesday, December 24, 2025
Home Tags Pharmaceutical manufacturing

Tag: pharmaceutical manufacturing

Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)
Brands in Conversation

Granules Pharmaceuticals Inc. Receives FDA Tentative Approval for Generic Amphetamine Extended-Release Orally Disintegrating Tablets (ADZENYS XR-ODT®)

Author -
0
Granules Life Sciences Receives First U.S. FDA Approval for Hyderabad Facility
Announcement &Achievement

Granules Life Sciences Receives First U.S. FDA Approval for Hyderabad Facility

Passionate in Marketing -
0
OneSource's flagship drug-device combination facility in Bangalore maintains its USFDA compliance status
Collaboration & Partnerships

OneSource’s flagship drug-device combination facility in Bangalore maintains its USFDA compliance status

Author -
0
Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg
Health/ Lifestyle & Entertainment

Zydus receives final approval from USFDA for Ibuprofen and Famotidine Tablets, 800 mg/26.6 mg

Passionate in Marketing -
0
India’s AI Leap: The Rise of CRIUS Group as a Model for the Tech-Driven CDMOS in Nutraceuticals.
Articles

India’s AI Leap: The Rise of CRIUS Group as a Model for the Tech-Driven CDMOS in Nutraceuticals.

Passionate in Marketing -
0
Standard Glass Lining Technology Limited’s Initial Public Offering to open on Monday, January 6, 2025, price band set at ₹133/- to ₹140/- per Equity Share
Brands in Conversation

Standard Glass Lining Technology Limited’s Initial Public Offering to open on Monday, January 6, 2025, price band set at ₹133/- to ₹140/- per Equity Share

Passionate in Marketing -
0
Standard Glass Lining Technology Limited’s Initial Public Offering to open on Monday, January 6, 2024, price band set at ₹133/- to ₹140/- per Equity Share
Articles

Standard Glass Lining Technology Limited’s Initial Public Offering to open on Monday, January 6, 2024, price band set at ₹133/- to ₹140/- per Equity Share

Passionate in Marketing -
0
Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.
Articles

Granules India Limited Announces FDA Approval for ADHD Treatment, Addressing Drug Shortages in the U.S.

Passionate in Marketing -
0
CORONA Remedies Strengthens Focus on Women Health with New Hormonal Products Manufacturing Plant
Articles

CORONA Remedies Strengthens Focus on Women Health with New Hormonal Products Manufacturing Plant

Passionate in Marketing -
0
Granules India’s Unit V Facility Secures US FDA EIR With ‘No Action Indicated’ Status
Articles

Granules India’s Unit V Facility Secures US FDA EIR With ‘No Action Indicated’ Status

Passionate in Marketing -
0
12Page 1 of 2

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Passionate in Marketing is promoted by i-miRa Knowledge Solutions, a company founded in 2010 to foster various business units dedicated to creating, disseminating, and managing knowledge-based products, services, and solutions. These offerings cater to corporate entities, startups, and academic institutions alike.

Contact : [email protected]

FOLLOW US

© 2025| Passionate In Marketing |All Rights Reserved | Privacy Policy